Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,063
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 4×
“These tests are quite sensitive and relatively specific to all major classes of antidepressant drugs including tricyclics, serotonin-specific reuptake inhibitors, monoamine oxidase inhibitors, and atypicals [6, 8, 20].”
BackgroundMethodInfluentialEndogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry
Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687 · cited 1×
“Furthermore, the brainstem-spinal monoaminergic systems play important roles in the transmission of nociceptive information from primary afferent neurons in the spinal dorsal horn, having a modulatory role in pain processing [5, 16].”
BackgroundA molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · cited 1×
“Noradrenaline and serotonin are believed to be involved in the mechanism of action of tricyclic antidepressants, and probably correct the monoamine deficiency by bringing about an increased availability of amines at postsynaptic receptor sites through an inhibition of the uptake of either or both of the monoamines [32…”
BackgroundThe induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774 · cited 5×
“Pain is a symptom of many clinical disorders, afflicts a large proportion of the population and is largely treated by various classes of drugs, such as monoaminergic antidepressant drugs [5].”
BackgroundInfluentialDetke, M. J., Rickels, M., & Lucki, I. (1995) · Psychopharmacology · doi:10.1007/bf02245592 · Cited by 1,433
The validity of animal models of depression
Willner, P. (1984) · Psychopharmacology · doi:10.1007/bf00427414 · Cited by 1,409 · cited 1×
“The TST, a derivative of the FST, shares with FST the ability to induce a state of immobility, sometimes referred to as behavioural despair, in animals, which is claimed to reproduce a condition akin to human depression [6, 22].”
BackgroundPorsolt, R. D., Bertin, A., Blavet, N., Deniel, M., & Jalfre, M. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90366-2 · Cited by 575 · cited 1×
“Both FST and TST are widely used as animal models of depression to screen new antidepressant drugs [6, 8, 18, 19].”
BackgroundHyperforin as a possible antidepressant component of hypericum extracts
Chatterjee, S. S., Bhattacharya, S. K., Wonnemann, M., Singer, A., & Müller, W. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00299-9 · Cited by 443 · cited 2×
“Striatum was prepared for [ 3 H]dopamine and cerebral cortices for [ 3 H]serotonin and [ 3 H]noradrenaline uptake experiments [10, 11].”
MethodTransmitters involved in antinociception in the spinal cord
Fürst, S. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00159-2 · Cited by 357 · cited 2×
“agement and treatment is probably one of the most common and yet most difficult aspects of medical practice [5, 14, 15].”
BackgroundAntidepressants for the new millennium
Skolnick, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00330-1 · Cited by 355 · cited 2×
“A growing amount of experimental data indicates that NMDA receptors may be involved in the mechanism of action of antidepressant drugs, and, by implication, in the pathogenesis of depression [31].”
BackgroundEffects of Hypericum Extract (LI 160) in Biochemical Models of Antidepressant Activity
Müller, W., Rolli, M., Schäfer, C., & Hafner, U. (1997) · Pharmacopsychiatry · doi:10.1055/s-2007-979528 · Cited by 276 · cited 1×
“Striatum was prepared for [ 3 H]dopamine and cerebral cortices for [ 3 H]serotonin and [ 3 H]noradrenaline uptake experiments [10, 11].”
MethodClinical Aspects of Depression in Chronic Pain Patients
Dworkin, R. H., & Gitlin, M. J. (1991) · The Clinical Journal of Pain · doi:10.1097/00002508-199106000-00004 · Cited by 221 · cited 1×
“Depression and anxiety often coexist with chronic pain [13].”
BackgroundGuanosine and GMP prevent seizures induced by quinolinic acid in mice
Schmidt, A. P., Lara, D. R., de Faria Maraschin, J., da Silveira Perla, A., & Onofre Souza, D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02106-5 · Cited by 178
Moret, C., Charveron, M., Finberg, J. P. M., Couzinier, J. P., & Briley, M. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90157-1 · Cited by 172 · cited 2×
“Noradrenaline and serotonin are believed to be involved in the mechanism of action of tricyclic antidepressants, and probably correct the monoamine deficiency by bringing about an increased availability of amines at postsynaptic receptor sites through an inhibition of the uptake of either or both of the monoamines [32…”
BackgroundPini, L. A., Sandrini, M., & Vitale, G. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00261-0 · Cited by 168 · cited 1×
“In the present study, prior administration of PCPA (an inhibitor of serotonin synthesis), at a dose known to inhibit serotonin synthesis [26], completely reduced the antidepressant-like action caused by either extract or fluoxetine (selective serotonin reuptake inhibitor), leaving the antidepressant action caused by i…”
MethodThe tail suspension test: Ethical considerations
Thierry, B., St�ru, L., Simon, P., & Porsolt, R. D. (1986) · Psychopharmacology · doi:10.1007/bf00181261 · Cited by 141 · cited 1×
“It has been argued that the TST is less stressful than FST and has greater pharmacological sensitivity [23].”
BackgroundNeurochemical alterations of serotonergic neuronal systems in depression.
Risch, S. C., & Nemeroff, C. B. (1992) · PubMed · Cited by 139
Conventional and new antidepressant drugs in the elderly
Gareri, P., Falconi, U., Fazio, P. D., & Sarro, G. D. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00050-7 · Cited by 138 · cited 1×
“In addition, despite extensive efforts and considerable progress made during the past five decades, successful treatment of clinical depression with currently available therapeutic agents can be achieved only in 65 to 75% of patients and only 40 to 50% achieve complete recovery [34–36].”
BackgroundChronic Neuropathic Pain and Its Control by Drugs
MacFarlane, B., Wright, A., O'Callaghan, J. P., & Benson, H. A. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00019-3 · Cited by 137 · cited 2×
“agement and treatment is probably one of the most common and yet most difficult aspects of medical practice [5, 14, 15].”
BackgroundEffect of Perinatal Lead Exposure on Rat Behaviour in Open‐Field and Two‐Wky Avoidance Tasks
Rodrigues, A. L. S., Rocha, J. B. T., Mello, C. F., & Souza, D. O. (1996) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1996.tb00259.x · Cited by 136
Self-citationda Silva, G. D. L., Matteussi, A. S., dos Santos, A. R. S., Calixto, J. B., & Rodrigues, A. L. S. (2000) · NeuroReport · doi:10.1097/00001756-200011270-00022 · Cited by 122 · cited 3×
“Recent studies from our group have shown that the precursor of nitric oxide, L-arginine, and the inhibitor of nitric oxide synthase, L-NNA, depending on their used dose, produced antidepressant-like effects in FST and TST [7].”
BackgroundMethodSelf-citationSantos, A. R. S., Miguel, O. G., Yunes, R. A., & Calixto, J. Β. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38152-2 · Cited by 99
Self-citationAcute treatments with GMP produce antidepressant-like effects in mice
Eckeli, A. L., Dach, F., & Rodrigues, A. L. S. (2000) · NeuroReport · doi:10.1097/00001756-200006260-00008 · Cited by 83 · cited 2×
“[12] have shown that GMP produced antidepressant-like effects by i.”
BackgroundSelf-citationDrug Treatment of Depression in the 1990s: An Overview of Achievements and Future Possibilities
Möller, H., & Volz, H. (1996) · Drugs · doi:10.2165/00003495-199652050-00001 · Cited by 79
Malcon, C., Achaval, M., Komlós, F., Partata, W. A., Sauressig, M., Ramírez, G., & Souza, D. O. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00225-5 · Cited by 61 · cited 1×
“GMP is an endogenous nucleotide known to be present at a high concentration in the central nervous system [27] that may be a neuroprotective agent that modulates the glutamatergic system, possibly by acting as a partial agonist at the NMDA receptor [28–30].”
BackgroundRubin, M. A., Jurach, A., Zanolla, G. R., Boemo, R. L., Souza, D. O., & Mello, C. F. (1997) · Neuroreport · doi:10.1097/00001756-199712010-00011 · Cited by 27 · cited 1×
“GMP is an endogenous nucleotide known to be present at a high concentration in the central nervous system [27] that may be a neuroprotective agent that modulates the glutamatergic system, possibly by acting as a partial agonist at the NMDA receptor [28–30].”
BackgroundFilho, R. R., & Takahashi, R. N. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001637 · Cited by 24
Trentin, A. P., Santos, A. R. S., Miguel, O. G., Pizzolatti, M. G., Yunes, R. A., & Calixto, J. Β. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06843.x · Cited by 22 · cited 5×
“verticillatus, apart from its reported antinociceptive actions [2], may have potential therapeutic value for the management of depressive disorders.”
BackgroundMethodSelf-citationThe dopamine D2 receptor antagonist sulpiride causes long-lasting serotonin release
Nakazato, T., Horikawa, H., & Akiyama, A. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00796-1 · Cited by 15 · cited 1×
“It has been shown that sulpiride may induce a short-term suppression of serotonin release [24], which could explain the blockade of the extract effect in the TST by sulpiride pre-treatment.”
BackgroundBopaiah, C. P., Pradhan, N., & Venkataram, B. S. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(00)00232-4 · Cited by 13
Cited by
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
Dutra, R. C., Campos, M. M., Santos, A. R. S., & Calixto, J. B. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.021 · Cited by 439
Self-citationTherapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
Zhang, Z.-J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.014 · Cited by 344
Ghia, J.-E., Blennerhassett, P., & Collins, S. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32849 · Cited by 233
Machado, D. G., Bettio, L. E. B., Cunha, M. P., Santos, A. R. S., Pizzolatti, M. G., Brighente, I. M. C., & Rodrigues, A. L. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.021 · Cited by 208
“Moreover, the same treatment with PCPA was previously shown by our group to completely prevent the antidepressant-like effect of fluoxetine, leaving the antidepressant action caused by imipramine in the tail suspension test unaffected (Rodrigues et al., 2002).”
BackgroundMethodResultInfluentialSelf-citation
Metadata
- Authors
- Rodrigues, A. L. S., da Silva, G. L., Mateussi, A. S., Fernandes, E. S., Miguel, O. G., Yunes, R. A., Calixto, J. B., & Santos, A. R. S.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 70
- Issue
- 12
- Pages
- 1347-1358
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2040927330
- Cited by
- 206
- References
- 31
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.